DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates" report to their offering.
The Pharmaceutical market was estimated to be worth $3.05 billion in 2015 and expected to reach $5.71 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 13.4% over the 2008-2020 period. The medical device market was valued at $664m in 2008 and is expected to reach approximately $810m by 2020, at a projected CAGR of 4.1%.
These positive trends can primarily be attributed to
- Growing medical tourism, healthcare infrastructure, expanding health insurance and increasing health expenditure
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
Scope
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Julphar, Neopharma, Pfizer, GlaxoSmithKline, Novartis)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UAE healthcare market
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Overview of Pharmaceutical and Medical Device Markets
4 Market Access
5 Country Analysis
6 Opportunities and Challenges
7 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/n5jxdq/countryfocus
